Pfizer Korea's diuretic drug Aldactone, which was often sold out, is scheduled to resume supply.

According to the distribution industry on the 27th, the supply of Aldactone (Spironolactone) 25mg is expected to resume from the 29th. It was earlier than the April 8th, the resupply date originally expected by the company.

Aldactone is often sold out due to continued supply disruption. Last year, there were five reports of production, import, and supply interruptions and shortages to the MFDS.

In December of last year, Pfizer expected to resume supply around February, but it was postponed for another two months. This is because it has not been able to resolve the supply and de